by Canadian Cannabis Exchange | Mar 28, 2025 | News
Australia’s medical cannabis industry is on a remarkable growth trajectory, with revenues projected to double from approximately USD $600 million in 2024 to over USD $1.2 billion by 2028, according to the Global Cannabis Report: 5th Edition by Prohibition...
by Canadian Cannabis Exchange | Mar 28, 2025 | News
The Greek medical cannabis industry is experiencing rapid growth, with Curity Pharma emerging as a key player in its evolution. On March 4, 2025, Curity Pharma announced that it had secured its operating license from Greek regulatory authorities. This milestone grants...
by Canadian Cannabis Exchange | Feb 6, 2025 | News
Neobi is excited to contribute to this year’s CCX Annual Report with data driven insights derived from several of our data sources. The Extracts category saw strong early-year growth but declined in Q4, likely due to seasonal demand or competition. Innovative product...
by Canadian Cannabis Exchange | Feb 3, 2025 | News
In 2024, cannabis companies saved significantly by reassessing insurance portfolios. By year-end, many insurers adopted assertive underwriting to meet new business goals. With new market entrants, the 2025 outlook is favorable for cannabis industry insurance buyers....
by Canadian Cannabis Exchange | Mar 27, 2024 | News
Since 2021, the unpaid Canada Revenue Agency (“CRA”) excise tax has been a growing concern for the government agency and unpaid amounts ballooned to $273.4 million in 2023[1]. In response to the increasing amount of unpaid taxes, the CRA has announced it will force...
